CCM® therapy is covered by Medicare

Medicare and Medicare Advantage cover CCM® therapy for FDA-indicated patients aged 18 or older who have not undergone a heart transplant.
Click here for more information
  • Home
  • Patients
    • Causes
    • Symptoms
    • Diagnosis
    • Treatment
    • Patient Stories
  • Providers
    • Indications & Patient Selection
    • Procedure and Mode of Action
    • Heart Failure Resources
    • Reimbursement
    • Instructions for Use and Product Manuals
  • Our Science
    • Clinical Studies
      • Aim Higher Study
      • Integra-D
    • Publications
  • Company
    • Executive Team
    • News Center
    • Safety Information
    • Ethics & Compliance
    • Grants & Donations
    • Careers
    • Contact Us
  • Find A Provider
  • REGION
    • North America
      • United States
      • Pacific
      • Australia
      • New Zeland
    • Pacific
      • Australia
      • New Zeland
    • Europe
      • Austria
      • Belgium
      • Czech Republic
      • Denmark
      • Finland
      • France
    • Europe
      • Germany
      • Hungary
      • Ireland
      • Italy
      • Netherlands
      • Norway
    • Europe
      • Poland
      • Portugal
      • Spain
      • Sweden
  • Home
  • Patients
    • Causes
    • Symptoms
    • Diagnosis
    • Treatment
    • Patient Stories
  • Providers
    • Indications & Patient Selection
    • Procedure and Mode of Action
    • Heart Failure Resources
    • Reimbursement
    • Instructions for Use and Product Manuals
  • Our Science
    • Clinical Studies
      • Aim Higher Study
      • Integra-D
    • Publications
  • Company
    • Executive Team
    • News Center
    • Safety Information
    • Ethics & Compliance
    • Grants & Donations
    • Careers
    • Contact Us
  • Find A Provider
  • REGION
    • North America
      • United States
      • Pacific
      • Australia
      • New Zeland
    • Pacific
      • Australia
      • New Zeland
    • Europe
      • Austria
      • Belgium
      • Czech Republic
      • Denmark
      • Finland
      • France
    • Europe
      • Germany
      • Hungary
      • Ireland
      • Italy
      • Netherlands
      • Norway
    • Europe
      • Poland
      • Portugal
      • Spain
      • Sweden

Impulse Dynamics Announces First Enrollment in Post-Approval Study of CCM Therapy Delivered by the Optimizer System

by Impulse Dynamics | Mar 17, 2020 | Press Releases

NEWS Impulse Dynamics Announces First Enrollment in Post-Approval Study of CCM Therapy Delivered by the Optimizer System Post-Approval Study will evaluate real-world safety and efficacy evidence for breakthrough heart failure therapy MOUNT LAUREL, N.J. – March 17,...

Impulse Dynamics Appoints Medical Director to Leadership Team

by Impulse Dynamics | Mar 10, 2020 | Press Releases

NEWS Impulse Dynamics Appoints Medical Director to Leadership Team Ishu Rao, M.D., brings wealth of clinical expertise during time of rapid company growth MOUNT LAUREL, N.J. – March 10, 2020 Impulse Dynamics, a company dedicated to improving the lives of people with...

Impulse Dynamics Secures $80.25 Million Financing

by Impulse Dynamics | Dec 3, 2019 | Press Releases

NEWS IMPULSE DYNAMICS SECURES $80.25 MILLION FINANCING Funding to Accelerate Commercialization of the Optimizer Smart System for Heart Failure MOUNT LAUREL, N.J. – December 3, 2019 – Impulse Dynamics, developer of Optimizer® Smart System for delivering CCM™ therapy,...

Impulse Dynamics Secures Transitional Pass-through (TPT) Incremental Payment for the Optimizer Smart System

by Impulse Dynamics | Nov 5, 2019 | Press Releases

NEWS Impulse Dynamics Secures Transitional Pass-through (TPT) Incremental Payment for the Optimizer Smart System 2020 Payment Rules from the Centers for Medicare and Medicaid Services Bring CCM Therapy to Heart Failure Patients in the Outpatient Setting Mount Laurel,...

First Optimizer® Smart Device Implanted in China

by Impulse Dynamics | Nov 1, 2019 | Press Releases

NEWS First Optimizer® Smart Device Implanted in China Mount Laurel, NJ, November 1, 2019 – On October 29, 2019, the first Optimizer Smart Cardiac Contractility Modulation CCMTM device was implanted in China at the Boao Super Hospital. Impulse Dynamics’ Optimizer Smart...
« Older Entries
Next Entries »

Recent Posts

  • Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy
  • Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy
  • Late-breaking Results Show Efficacy for CCM in Patients With HFpEF
  • IMPULSE DYNAMICS COMPLETES $101M FINANCING ROUND
  • IMPULSE DYNAMICS ANNOUNCES FIRST IMPLANTS OF OPTIMIZER SMART MINI

Recent Comments

    Archives

    • November 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • January 2022
    • November 2021
    • October 2021
    • July 2021
    • February 2021
    • January 2021
    • April 2020
    • March 2020
    • December 2019
    • November 2019
    • October 2019
    • July 2019
    • March 2019
    • May 2018
    • December 2017
    • August 2017
    • May 2017
    • March 2017
    • September 2016
    • May 2016
    • March 2016
    • January 2016
    • November 2015
    • August 2015
    • July 2015
    • January 2015
    • December 2014

    Categories

    • News and Events
    • Press Releases

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org